[1]
N. R. Datta, E. Stutz, S. Rogers, and S. Bodis, “Clinical estimation of α/β values for prostate cancer from isoeffective phase III randomized trials with moderately hypofractionated radiotherapy”, AO, vol. 57, no. 7, pp. 883–894, Jul. 2018.